Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved weight loss and diabetes medications that are transforming communities across America. Medications like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) are now available to patients in cities and towns of every size through licensed online telehealth — not just in major urban centers with specialist clinics.
Clinical trials show that community members using GLP-1 medications lose an average of 15-22% of their body weight, reducing the burden of obesity-related conditions like type 2 diabetes, high blood pressure, and heart disease — improving quality of life not just for individuals, but for communities as a whole.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 6, 2026
Whether you live in a major city or a rural town, our network of state-licensed physicians serves your community online. No need to travel hours to see a specialist — bring the specialist to your home.
All prescribed medications — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda) — are FDA-approved and trusted by patients and physicians across the country.
Every prescribing physician holds an active license in your state and understands local healthcare regulations, community health needs, and available resources. Local knowledge, national network.
Three landmark randomized controlled trials in the New England Journal of Medicine form the evidence base for FDA-approved GLP-1 weight management medications:
Telehealth prescribing of GLP-1 medications is fully legal in all 50 states when conducted by a properly licensed physician through a HIPAA-compliant platform. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are not DEA-scheduled controlled substances — no in-person visit is required by federal or state telehealth law.
Adult obesity rates (CDC Behavioral Risk Factor Surveillance System, 2023) vary significantly across the United States. States with higher obesity prevalence experience the greatest demand for accessible GLP-1 telehealth prescriptions:
Source: CDC Behavioral Risk Factor Surveillance System (BRFSS) 2023. Adult obesity defined as BMI ≥ 30.0.
Choose your state to explore the local communities and cities in our GLP-1 telehealth provider network.
From the biggest cities to growing communities, GLP-1 telehealth providers are reaching patients where they live. Select your city.
We have built a simple, community-oriented process to connect you with a licensed GLP-1 prescriber in your state — no matter where you live.
Complete a quick, secure health profile that helps your local licensed physician understand your background, health history, and weight management goals. It takes just a few minutes and is completely confidential.
A physician licensed in your state reviews your profile and meets with you via telehealth. They understand your local community, your state's healthcare landscape, and will create a personalized GLP-1 treatment plan just for you.
Your GLP-1 medication is shipped from a licensed US pharmacy directly to your home address — anywhere in the country. Most patients in your community receive their medication within 3-5 business days.
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Absolutely. Our telehealth network was built specifically to reach patients in communities that lack local specialist access. If you have an internet connection, you can connect with a licensed GLP-1 prescriber in your state — regardless of where you live.
Yes, always. Every physician in our network holds an active medical license in the state where you reside. They comply with all state and federal telehealth prescribing regulations, ensuring your prescription is fully legal and valid in your community.
Clinical trial data shows average weight loss of 15-22% of body weight over approximately 72 weeks of treatment. In real-world community settings, patients consistently achieve meaningful weight reduction along with improvements in blood sugar, blood pressure, and overall quality of life.
Yes. Licensed US pharmacies will ship your GLP-1 medication to any residential or PO box address in all 50 states. Delivery typically takes 3-5 business days. Temperature-controlled packaging ensures medication integrity regardless of your location.
Online GLP-1 care offers the same medical expertise as an in-person specialist visit, but delivered to your home. Telehealth physicians specialize in metabolic health and GLP-1 prescribing, often providing more focused expertise than a general practitioner, while eliminating the cost and inconvenience of office visits.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
